Is cancer immunotherapy more effective in men than women?May 16, 2018Immuno-oncologyImmunotherapyGenitourinary CancerGastroenterologyRenal Cell CarcinomaMelanomaLung Cancer
Outpatient CAR T infusions feasible using liso-celMarch 12, 2018Lymphoma & Plasma Cell DisordersImmunotherapyFollicular Lymphoma
Cancer groups offer guidance on immune-related adverse eventsMarch 9, 2018Immuno-oncologyPatient & Survivor CareImmunotherapy
ERV expression may predict response to immune checkpoint blockade in ccRCC, other solid tumorsFebruary 9, 2018Renal Cell CarcinomaImmunotherapy
AML immune profiles correlate with relapse-free survivalFebruary 4, 2018ImmunotherapyLeukemia, Myelodysplasia, Transplantation
CAR T cells produce longest survival in low disease burden ALL patientsJanuary 31, 2018Leukemia, Myelodysplasia, TransplantationImmunotherapy
Combination immunotherapy is active in dMMR/MSI-H metastatic colorectal cancerJanuary 26, 2018Immuno-oncologyGastroenterologyImmunotherapyGastrointestinal Cancer
Phase 1 study: Human IL-10 plus checkpoint blockade looks promising in RCC, NSCLCJanuary 11, 2018Renal Cell CarcinomaLung CancerImmunotherapy
Updated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Lymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncologyFollicular Lymphoma
DNA vaccine + PD-1 blockade shows promise in mCRPCDecember 9, 2017Immuno-oncologyImmunotherapyGenitourinary Cancer
Nivolumab may extend survival in HCC patientsNovember 7, 2017ImmunotherapyGastroenterologyGastrointestinal Cancer
Checkmate 214: Upfront nivo/ipi bests TKI in advanced RCCSeptember 28, 2017Renal Cell CarcinomaImmunotherapyImmuno-oncology
